Activation of the calcium-sensing receptor promotes apoptosis by modulating the JNK/p38 MAPK pathway in focal cerebral ischemia-reperfusion in mice

American Journal of Translational Research

Volumn 8, Issue 2, 2016, Pages 911-921

  Zhen, Yilan ^a   Ding, Caijuan ^a,b   Sun, Jiaqiang ^c   Wang, Yanan ^a   Li, Sheng ^a   Dong, Liuyi ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b Tongling Polytechnic   (China)

^c ANHUI PROVINCIAL HOSPITAL   (China)

Author keywords

Apoptosis; Calcium sensing receptor (CaSR); Focal cerebral ischemia reperfusion; MAPK; Mice

Indexed keywords

CALCIUM SENSING RECEPTOR; GADOLINIUM CHLORIDE; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE P38; NPS2390; PROTEIN BAX; PROTEIN BCL 2; PROTEIN INHIBITOR; STRESS ACTIVATED PROTEIN KINASE; TRIPHENYLTETRAZOLIUM; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; HISTOPATHOLOGY; MALE; MOUSE; NERVOUS SYSTEM FUNCTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84962090275     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Pang X, Li T, Feng L, Zhao J, Zhang X and Liu J. Ellagic acid-induced thrombotic focal cerebral ischemic model in rats. J Pharmacol Toxicol Methods 2014; 69: 217-222.
2. Deb P, Sharma S and Hassan KM. Pathophysiologic mechanisms of acute ischemic stroke: An overview with emphasis on therapeutic significance beyond thrombolysis. Pathophysiology 2010; 17: 197-218.
3. Auriel E and Bornstein NM. Neuroprotection in acute ischemic stroke--current status. J Cell Mol Med 2010; 14: 2200-2202.
4. Brown EM, Gamba G, Riccardi D, Lombardi M, Butters R, Kifor O, Sun A, Hediger MA, Lytton J and Hebert SC. Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature 1993; 366: 575-580.
5. Bai M. Structure and function of the extracellular calcium-sensing receptor (Review). Int J Mol Med 1999; 4: 115-125.
6. Bai M, Trivedi S, Lane CR, Yang Y, Quinn SJ and Brown EM. Protein kinase C phosphorylation of threonine at position 888 in Ca2+o-sensing receptor (CaR) inhibits coupling to Ca2+ store release. J Biol Chem 1998; 273: 21267-21275.
7. Jung SY, Kwak JO, Kim HW, Kim DS, Ryu SD, Ko CB and Cha SH. Calcium sensing receptor forms complex with and is up-regulated by caveolin-1 in cultured human osteosarcoma (Saos-2) cells. Exp Mol Med 2005; 37: 91-100.
8. Bevilacqua M, Dominguez LJ, Righini V, Valdes V, Toscano R, Sangaletti O, Vago T, Baldi G, Barrella M and Bianchi-Porro G. Increased gastrin and calcitonin secretion after oral calcium or peptones administration in patients with hypercalciuria: a clue to an alteration in calciumsensing receptor activity. J Clin Endocrinol Metab 2005; 90: 1489-1494.
9. Smajilovic S and Tfelt-Hansen J. Calcium acts as a first messenger through the calcium-sensing receptor in the cardiovascular system. Cardiovasc Res 2007; 75: 457-467.
10. Brown EM and MacLeod RJ. Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 2001; 81: 239-297.
11. Fellner SK and Parker L. Ionic strength and the polyvalent cation receptor of shark rectal gland and artery. J Exp Zool A Comp Exp Biol 2004; 301: 235-239.
12. Wang R, Xu C, Zhao W, Zhang J, Cao K, Yang B and Wu L. Calcium and polyamine regulated calcium-sensing receptors in cardiac tissues. Eur J Biochem 2003; 270: 2680-2688.
13. Sun YH, Liu MN, Li H, Shi S, Zhao YJ, Wang R and Xu CQ. Calcium-sensing receptor induces rat neonatal ventricular cardiomyocyte apoptosis. Biochem Biophys Res Commun 2006; 350: 942-948.
14. Longa EZ, Weinstein PR, Carlson S and Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989; 20: 84-91.
15. Choi BI, Park D, Lee SH, Bae DK, Yang G, Yang YH, Kim TK, Choi EK, Lee HJ, Choi KC, Nahm SS and Kim YB. Neurobehavioural deficits correlate with the cerebral infarction volume of stroke animals: a comparative study on ischaemia-reperfusion and photothrombosis models. Environ Toxicol Pharmacol 2012; 33: 60-69.
16. Jin YL, Dong LY, Wu CQ, Qin J, Li S, Wang CY, Shao X and Huang DK. Buyang Huanwu Decoction fraction protects against cerebral ischemia/reperfusion injury by attenuating the inflammatory response and cellular apoptosis. Neural Regen Res 2013; 8: 197-207.
17. Wang LN, Wang C, Lin Y, Xi YH, Zhang WH, Zhao YJ, Li HZ, Tian Y, Lv YJ, Yang BF and Xu CQ. Involvement of calcium-sensing receptor in cardiac hypertrophy-induced by angiotensinII through calcineurin pathway in cultured neonatal rat cardiomyocytes. Biochem Biophys Res Commun 2008; 369: 584-589.
18. Abbate A, Biondi-Zoccai GG and Baldi A. Pathophysiologic role of myocardial apoptosis in post-infarction left ventricular remodeling. J Cell Physiol 2002; 193: 145-153.
19. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007; 35, 495-516.
20. Schmitz I, Kirchhoff S and Krammer PH. Regulation of death receptor-mediated apoptosis pathways. Int J Biochem Cell Biol 2000; 32, 1123-1136.
21. Dejean LM, Martinez-Caballero S, Manon S and Kinnally KW. Regulation of the mitochondrial apoptosis-induced channel, MAC, by BCL-2 family proteins. Biochim Biophys Acta 2006; 1762: 191-201.
22. Jin HW, Ichikawa H, Nomura K, Mukae K, Terayama R, Yamaai T and Sugimoto T. Activation of the caspase cascade underlies the rat trigeminal primary neuronal apoptosis induced by neonatal capsaicin administration. Arch Histol Cytol 2005; 68: 301-310.
23. Kotipatruni RR, Dasari VR, Veeravalli KK, Dinh DH, Fassett D and Rao JS. p53-and Baxmediated apoptosis in injured rat spinal cord. Neurochem Res 2011; 36: 2063-2074.
24. Youle RJ and Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 2008; 9: 47-59.
25. Kim H, Rafiuddin-Shah M, Tu HC, Jeffers JR, Zambetti GP, Hsieh JJ and Cheng EH. Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Nat Cell Biol 2006; 8: 1348-1358.
26. Liu C, Shi Z, Fan L, Zhang C, Wang K and Wang B. Resveratrol improves neuron protection and functional recovery in rat model of spinal cord injury. Brain Res 2011; 1374: 100-109.
27. Wang Y, Sun ZY, Zhang KM, Xu GQ and Li G. Bcl-2 in suppressing neuronal apoptosis after spinal cord injury. World J Emerg Med 2011; 2: 38-44.
28. Kyriakis JM and Avruch J. Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. Physiol Rev 2012; 92: 689-737.
29. Garrington TP and Johnson GL. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr Opin Cell Biol 1999; 11: 211-218.
30. Son Y, Cheong YK, Kim NH, Chung HT, Kang DG and Pae HO. Mitogen-Activated Protein Kinases and Reactive Oxygen Species: How Can ROS Activate MAPK Pathways? J Signal Transduct 2011; 2011: 792639.
31. Lu Q, Rau TF, Harris V, Johnson M, Poulsen DJ and Black SM. Increased p38 mitogen-activated protein kinase signaling is involved in the oxidative stress associated with oxygen and glucose deprivation in neonatal hippocampal slice cultures. Eur J Neurosci 2011; 34: 1093-1101.
32. Wang YX, Xu XY, Su WL, Wang Q, Zhu WX, Chen F, Jin G, Liu YJ, Li YD, Sun YP, Gao WC and Ruan CP. Activation and clinical significance of p38 MAPK signaling pathway in patients with severe trauma. J Surg Res 2010; 161: 119-125.
33. Wang Z, Chen X, Zhou L, Wu D, Che X and Yang G. Effects of extracellular signal-regulated kinase (ERK) on focal cerebral ischemia. Chin Med J (Engl) 2003; 116: 1497-1503.
34. Xia Z, Dickens M, Raingeaud J, Davis RJ and Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995; 270: 1326-1331.
35. Hetman M and Xia Z. Signaling pathways mediating anti-apoptotic action of neurotrophins. Acta Neurobiol Exp (Wars) 2000; 60: 531-545.
36. Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, Bar-Sagi D, Jones SN, Flavell RA and Davis RJ. Requirement of JNK for stressinduced activation of the cytochrome c-mediated death pathway. Science 2000; 288: 870-874.
37. Irving EA, Barone FC, Reith AD, Hadingham SJ and Parsons AA. Differential activation of MAPK/ERK and p38/SAPK in neurones and glia following focal cerebral ischaemia in the rat. Brain Res Mol Brain Res 2000; 77: 65-75.
38. Barone FC, Irving EA, Ray AM, Lee JC, Kassis S, Kumar S, Badger AM, White RF, McVey MJ, Legos JJ, Erhardt JA, Nelson AH, Ohlstein EH, Hunter AJ, Ward K, Smith BR, Adams JL and Parsons AA. SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia. J Pharmacol Exp Ther 2001; 296: 312-321.
39. Nito C, Kamada H, Endo H, Niizuma K, Myer DJ and Chan PH. Role of the p38 mitogen-activated protein kinase/cytosolic phospholipase A2 signaling pathway in blood-brain barrier disruption after focal cerebral ischemia and reperfusion. J Cereb Blood Flow Metab 2008; 28: 1686-1696.
40. Lennmyr F, Ericsson A, Gerwins P, Ahlstrom H and Terent A. Increased brain injury and vascular leakage after pretreatment with p38-inhibitor SB203580 in transient ischemia. Acta Neurol Scand 2003; 108: 339-345.
41. Ghatan S, Larner S, Kinoshita Y, Hetman M, Patel L, Xia Z, Youle RJ and Morrison RS. p38 MAP kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons. J Cell Biol 2000; 150: 335-347.